553 related articles for article (PubMed ID: 8585429)
21. Down-regulation of the receptor for parathyroid hormone (PTH) and PTH-related peptide by PTH in primary fetal rat osteoblasts.
Jongen JW; Willemstein-van Hove EC; van der Meer JM; Bos MP; Jüppner H; Segre GV; Abou-Samra AB; Feyen JH; Herrmann-Erlee MP
J Bone Miner Res; 1996 Sep; 11(9):1218-25. PubMed ID: 8864895
[TBL] [Abstract][Full Text] [Related]
22. Collagen, type V, alpha1 (COL5A1) is regulated by TGF-beta in osteoblasts.
Kahai S; Vary CP; Gao Y; Seth A
Matrix Biol; 2004 Nov; 23(7):445-55. PubMed ID: 15579311
[TBL] [Abstract][Full Text] [Related]
23. Parathyroid hormone-related protein regulates extracellular matrix gene expression in cementoblasts and inhibits cementoblast-mediated mineralization in vitro.
Ouyang H; McCauley LK; Berry JE; Saygin NE; Tokiyasu Y; Somerman MJ
J Bone Miner Res; 2000 Nov; 15(11):2140-53. PubMed ID: 11092395
[TBL] [Abstract][Full Text] [Related]
24. Role of Smad3, acting independently of transforming growth factor-beta, in the early induction of Wnt-beta-catenin signaling by parathyroid hormone in mouse osteoblastic cells.
Inoue Y; Canaff L; Hendy GN; Hisa I; Sugimoto T; Chihara K; Kaji H
J Cell Biochem; 2009 Sep; 108(1):285-94. PubMed ID: 19582775
[TBL] [Abstract][Full Text] [Related]
25. Regulation of collagen type I and biglycan mRNA levels by hormones and growth factors in normal and immortalized osteoblastic cell lines.
Thiébaud D; Guenther HL; Porret A; Burckhardt P; Fleisch H; Hofstetter W
J Bone Miner Res; 1994 Sep; 9(9):1347-54. PubMed ID: 7817818
[TBL] [Abstract][Full Text] [Related]
26. Effects of transforming growth factor-beta and IL-1 alpha on prostaglandin synthesis in serum-deprived osteoblastic cells.
Marusić A; Kalinowski JF; Harrison JR; Centrella M; Raisz LG; Lorenzo JA
J Immunol; 1991 Apr; 146(8):2633-8. PubMed ID: 1707913
[TBL] [Abstract][Full Text] [Related]
27. Relationship between actions of transforming growth factor (TGF)-beta and cell surface expression of its receptors in clonal osteoblastic cells.
Takeuchi Y; Fukumoto S; Matsumoto T
J Cell Physiol; 1995 Mar; 162(3):315-21. PubMed ID: 7860639
[TBL] [Abstract][Full Text] [Related]
28. Cyclin D1 as a target for the proliferative effects of PTH and PTHrP in early osteoblastic cells.
Datta NS; Pettway GJ; Chen C; Koh AJ; McCauley LK
J Bone Miner Res; 2007 Jul; 22(7):951-64. PubMed ID: 17501623
[TBL] [Abstract][Full Text] [Related]
29. Anabolic or catabolic responses of MC3T3-E1 osteoblastic cells to parathyroid hormone depend on time and duration of treatment.
Schiller PC; D'Ippolito G; Roos BA; Howard GA
J Bone Miner Res; 1999 Sep; 14(9):1504-12. PubMed ID: 10469278
[TBL] [Abstract][Full Text] [Related]
30. Coordinate expression of novel genes during osteoblast differentiation.
Seth A; Lee BK; Qi S; Vary CP
J Bone Miner Res; 2000 Sep; 15(9):1683-96. PubMed ID: 10976989
[TBL] [Abstract][Full Text] [Related]
31. Conditionally immortalized murine osteoblasts lacking the type 1 PTH/PTHrP receptor.
Divieti P; Lanske B; Kronenberg HM; Bringhurst FR
J Bone Miner Res; 1998 Dec; 13(12):1835-45. PubMed ID: 9844101
[TBL] [Abstract][Full Text] [Related]
32. Bone morphogenetic protein-2 and transforming growth factor-beta2 interact to modulate human bone marrow stromal cell proliferation and differentiation.
Fromigué O; Marie PJ; Lomri A
J Cell Biochem; 1998 Mar; 68(4):411-26. PubMed ID: 9493905
[TBL] [Abstract][Full Text] [Related]
33. Parathyroid hormone-related protein is required for normal intramembranous bone development.
Suda N; Baba O; Udagawa N; Terashima T; Kitahara Y; Takano Y; Kuroda T; Senior PV; Beck F; Hammond VE
J Bone Miner Res; 2001 Dec; 16(12):2182-91. PubMed ID: 11760831
[TBL] [Abstract][Full Text] [Related]
34. The suppressive effect of enamel matrix derivative on osteocalcin gene expression of osteoblasts is neutralized by an antibody against TGF-beta.
Wada Y; Yamamoto H; Nanbu S; Mizuno M; Tamura M
J Periodontol; 2008 Feb; 79(2):341-7. PubMed ID: 18251649
[TBL] [Abstract][Full Text] [Related]
35. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells.
Franceschi RT; Iyer BS; Cui Y
J Bone Miner Res; 1994 Jun; 9(6):843-54. PubMed ID: 8079660
[TBL] [Abstract][Full Text] [Related]
36. Parathyroid hormone regulates osteoblast differentiation positively or negatively depending on the differentiation stages.
Isogai Y; Akatsu T; Ishizuya T; Yamaguchi A; Hori M; Takahashi N; Suda T
J Bone Miner Res; 1996 Oct; 11(10):1384-93. PubMed ID: 8889836
[TBL] [Abstract][Full Text] [Related]
37. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies.
Sterck JG; Klein-Nulend J; Burger EH; Lips P
J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947
[TBL] [Abstract][Full Text] [Related]
38. EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts.
Allan EH; Häusler KD; Wei T; Gooi JH; Quinn JM; Crimeen-Irwin B; Pompolo S; Sims NA; Gillespie MT; Onyia JE; Martin TJ
J Bone Miner Res; 2008 Aug; 23(8):1170-81. PubMed ID: 18627264
[TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential.
Wang D; Christensen K; Chawla K; Xiao G; Krebsbach PH; Franceschi RT
J Bone Miner Res; 1999 Jun; 14(6):893-903. PubMed ID: 10352097
[TBL] [Abstract][Full Text] [Related]
40. Role of protein kinase-A in homologous down-regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in human osteoblast-like SaOS-2 cells.
Fukayama S; Schipani E; Jüppner H; Lanske B; Kronenberg HM; Abou-Samra AB; Bringhurst FR
Endocrinology; 1994 Apr; 134(4):1851-8. PubMed ID: 8137752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
